Product Description
The encoded EBA G9 protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. It serves as a prognostic marker for cancers such as adenocarcinomas of the lung and breast cancers. It is present and overexpressed in many patients suffering from breast carcinomas. Human EZA G9 participates in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme-like proteases.
Biovision | P1629 | EBAG9 Protein, Human Recombinant DataSheet
Biomolecule/Target :
Synonyms: Estrogen receptor binding site associated antigen 9,Cancer-associated surface antigen RCAS1,RCAS 1,Estrogen receptor-binding fragment-associated gene 9 protein,EBAG 9,PDAF,Cancer associated surface antigen,EB9
Alternates names: Estrogen receptor binding site associated antigen 9,Cancer-associated surface antigen RCAS1,RCAS 1,Estrogen receptor-binding fragment-associated gene 9 protein,EBAG 9,PDAF,Cancer associated surface antigen,EB9
Taglines: Human protein with His tag
NCBI Gene ID #: 9166
NCBI Gene Symbol: NP_004206
Gene Source: Human
Accession #: NX_O00559, NP_004206
Recombinant: TRUE
Source: E.coli
Purity by SDS-PAGE: ≥ 90% by SDS-PAGE
Assay:
Purity:
Assay #2:
Endotoxin Level:
Activity (Specifications/test method):
Biological activity:
Results:
Binding Capacity:
Unit Definition:
Molecular Weight: 23.4 kDa (207aa) confirmed by MALDI-TOF (Molecular weight on SDS-PAGE will appear higher)
Concentration:
Appearance: Sterile Filtered colorless solution
Physical form description:
Reconstitution Instructions:
Amino acid sequence: 28-213aa
Handling: Centrifuge the vial prior to opening.
Usage: For Research Use Only! Not to be used in humans